Physician profile
John S Locke
NPI 1467520189
$3,171.90
in general payments reported to CMS, 2019-2025
13 companies · $114 in 2025
The $114 reported for 2025 was less than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,728 · 2020: $44.87 · 2021: $93.57 · 2023: $142 · 2024: $49.76 · 2025: $114.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $306.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $305.77 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Encore Medical, LP | $2,514.29 | 2019 | |
| Stryker Corporation | $150.21 | 2019-2023 | Mako |
| Janssen Pharmaceuticals, INC | $125.00 | 2019 | |
| Boston Scientific Corporation | $114.47 | 2025 | Axonics |
| Pacira Therapeutics, INC. | $66.96 | 2019-2021 | |
| Horizon Therapeutics Plc | $64.39 | 2020-2021 | |
| Vision Quest Industries INC. | $36.90 | 2024 | Oactive Align Custom R |
| Medtronic, INC. | $22.36 | 2023 | Mazor X System |
| Valeritas, INC. | $18.48 | 2019 | |
| Ferring Pharmaceuticals INC. | $18.15 | 2021 | |
| Abiomed | $14.84 | 2020 | |
| Sanofi-Aventis U.S. LLC | $12.99 | 2019 | |
| Vertos Medical, INC. | $12.86 | 2024 | Mild Device Kit |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Locke listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.